Free Research Report on Onyx Pharmaceuticals, Inc., Universal Health Services, Inc., Eastman Chemical Company, Varian Medical...

  Today, Traders Insight announced new research reports highlighting Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Universal Health Services, Inc. (NYSE: UHS), Eastman Chemical Company (NYSE: EMN), Varian Medical Systems, Inc. (NYSE: VAR) and Toronto-Dominion Bank (ON). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Onyx Pharmaceuticals, Inc. Research Report Onyx Pharmaceuticals, Inc. (Onyx) is a biopharmaceutical company. The Company is developing therapies that target the molecular mechanisms that cause cancer. The Company has built two franchise platforms: one in kinase inhibition and one in proteasome inhibition. In its kinase inhibitor franchise, its product, Nexavar (sorafenib) tablets is approved for unresectable liver cancer and advanced kidney cancer. unresectable liver cancer and advanced kidney cancer. The Full Research Report on Onyx Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [www.TradersInsight.net/r/2013-02-12/3c8f_ONXX]

Universal Health Services, Inc. Research Report Owns and manages private hospitals. The company owns acute care, psychiatric, and general hospitals, and offers management services such as data processing, finance and control systems, facilities planning, physician recruitment services, and administrative personnel management. » The Full Research Report on Universal Health Services, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [www.TradersInsight.net/r/2013-02-12/2559_UHS]

Eastman Chemical Company Research Report Eastman Chemical Company (Eastman) is a global chemical company, which manufactures and sells a portfolio of chemicals, plastics, and fibers. Eastman has 19 manufacturing sites in 10 countries and interests in joint ventures that supply chemicals, plastics, and fibers products to customers throughout the world. The Full Research Report on Eastman Chemical Company - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [www.TradersInsight.net/r/2013-02-12/0431_EMN]

Varian Medical Systems, Inc. Research Report Varian Medical Systems, Inc. is engaged in the design, manufacture, sale and service of equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and brachytherapy. The Full Research Report on Varian Medical Systems, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [www.TradersInsight.net/r/2013-02-12/406f_VAR]

Toronto-Dominion Bank (ON) Research Report The Toronto-Dominion Bank is a Canada-based bank. The Toronto-Dominion Bank and its subsidiaries are collectively known as TD Bank Group (the Bank or TD). The Bank serves approximately 20.5 million customers in four businesses operating in a number of locations in financial centres worldwide: Canadian Personal and Commercial Banking, including TD Canada Trust, TD Insurance, and TD Auto Finance Canada; Wealth Management, including TD Waterhouse and an investment in TD Ameritrade; U.S. The Full Research Report on Toronto-Dominion Bank (ON) - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [www.TradersInsight.net/r/2013-02-12/98c0]

About Traders Insight Our model of enabling open collaboration between members is breaking new ground into the investment community. By tapping into the resources of the community, we are crowd-sourcing our reach. As a result -- we have been able to identify some of the greatest moving companies on the market today. The evidence is in the results, join today and experience what you've been missing.

Press Contact: Cora S. Patton [e-mail]